Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Melanoma × binimetinib × Clear all

Phase

Phase 2 18 Phase 1 7 Phase 1/2 6 Phase 3 4 Phase EARLY_PHASE1 2 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumors 1 Melanoma 1

Interventions

Nivolumab 4 aldesleukin 3 Blood Specimen Collection 3 Vemurafenib 2 Ipilimumab 2 trametinib 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 technetium Tc 99m nanocolloid 1 sargramostim 1 relatlimab 1 pembrolizumab 1 pasireotide 1 encorafenib 1 dabrafenib 1 binimetinib 1 Vindesine 1 Standard of Care 1 Sevoflurane 1 Propofol 1 Pharmaceutical Preparations 1 Isoflurane 1 Interleukins 1 Interleukin-2 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fibrin Tissue Adhesive 1 Etanercept 1 Desflurane 1 Dacarbazine 1 Craniotomy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2025-07-29

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡